Safety/Efficacy Study of a Drug to Reduce Thrombocytopenia in Patients Receiving Chemotherapy for Ovarian, Fallopian Tube or Peritoneal Cancer

This study has been terminated.

( Insufficient incidence of thrombocytopenia in control population )

Study NCT00771810 Information provided by US Biotest, Inc.

First Received: October 9, 2008 Last Updated: December 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2011
Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)